#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Comparison of the most recent guidelines for hyperglycemia management in patients with type 2 diabetes mellitus


Authors: Zbynek Schroner 1;  Vladimír Uličiansky 2
Authors‘ workplace: SchronerMED s. r. o, Košice 1;  Via medica s. r. o., Košice 2
Published in: Diab Obez 2020; 20(39): 7-11
Category: Guidelines

Overview

New guidelines ADA/EASD 2018, also update 2019 for the management of hyperglycemia in type 2 diabetes emphasize as a second choice after metformin therapy, in patients with cardiovascular (CV) disease or high CV risk, chronic kidney disease, importance mainly of SGLT2 inhibitors and GLP-1 receptor agonists. These two classes have not only antidiabetic effects but also cardioprotective nad renoprotective benefits. 2019 ESC/EASD guidelines on diabetes, pre-diabetes, and CV diseases in patients with CV disease or high/very high CV risk recommend as first -line therapy not metformin but SGLT2 inhibitor or GLP-1 receptor agonist. Individualised approach is always important.

Keywords:

type 2 diabetes mellitus – new guidelines ADA/EASD and ESC/EASD


Sources
  1. Davies MJ, D Alessio DA, Fradkin J et al. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2018; 61(12): 2461–2498. Dostupné z DOI: <http://dx.doi.org/10.1007/s00125–018–4729–5>. Erratum in Correction to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). [Diabetologia 2019].
  2. Davies MJ, D Alessio DA, Fradkin J, et al. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2018; 41(12): 2669–2701. Dostupné z DOI: <http://dx.doi.org/10.2337/dci18–0033>.
  3. Buse JB, Wexler D, Tsapas A et al. 2019 update to: Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2020; 43(2): 487–493. Dostupné z DOI: <http://dx.doi.org/10.2337/dci19–0066>.
  4. Cosentino F, Grant PJ, Aboyans V et al. [ESC Scientific Document Group]. 2019 ESC Guidelines on diabetes, pre-diabetes and cardiovascular diseases developed in collaboration with EASD. Eur Heart J 2020; 41(2): 255–323. Dostupné z DOI: <https://doi: 10.1093/eurheartj/ehz486>.
  5. Martinka M, Uličiansky V, Mokáň M et al. Konsenzuálne terapeu­tické odporúčanie Slovenskej diabetologickej spoločnosti pre diabetes mellitus 2. typu. Forum Diab 2018; 7(1): 47–68.
Labels
Diabetology Obesitology

Article was published in

Diabetes and obesity

Issue 39

2020 Issue 39

Most read in this issue
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#